The prognostic and predictive value of serum CA19.9 in pancreatic cancer

@inproceedings{Humphris2012ThePA,
  title={The prognostic and predictive value of serum CA19.9 in pancreatic
cancer},
  author={Jeremy L. Humphris and Dong Kyung Chang and Amber L. Johns and Christopher J Scarlett and Marko Paji{\'c} and Marc D. Jones and Emily K. Colvin and Adnan Nagrial and Venessa T Chin and Lorraine A Chantrill and Jagbir S Samra and Anthony J Gill and James G Kench and N. D. Merrett and Asha Das and Elizabeth A. Musgrove and Robert Lyndsay Sutherland and A. V. Biankin},
  booktitle={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2012}
}
BACKGROUND Current staging methods for pancreatic cancer (PC) are inadequate, and biomarkers to aid clinical decision making are lacking. Despite the availability of the serum marker carbohydrate antigen 19.9 (CA19.9) for over two decades, its precise role in the management of PC is yet to be defined, and as a consequence, it is not widely used. METHODS We assessed the relationship between perioperative serum CA19.9 levels, survival and adjuvant chemotherapeutic responsiveness in a cohort of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 13 times over the past 90 days. VIEW TWEETS